Deletions of Retinoblastoma 1 (Rb1) and Its Repressing Target S Phase Kinase-associated protein 2 (Skp2) Are Synthetic Lethal in Mouse Embryogenesis

被引:10
|
作者
Zhao, Hongling
Wang, Hongbo [1 ]
Bauzon, Frederick
Lu, Zhonglei
Fu, Hao
Cui, Jinhua
Zhu, Liang
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA
基金
美国国家卫生研究院;
关键词
CELL-CYCLE; SUPPRESSES APOPTOSIS; NERVOUS-SYSTEM; MUTANT MICE; MUTATION; DEFICIENT; DEFECTS; PROLIFERATION; TUMORIGENESIS; EXTENDS;
D O I
10.1074/jbc.M116.718049
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor suppressor pith represses Skp2, a substrate-recruiting subunit of the SCFSkp2 ubiquitin ligase. Rb1(+/-) mice incur "two hit" pituitary tumorigenesis; Skp2(-/-);Rb1(+/-) mice do not Rb1(-/-) embryos die on embryonic day (E) 14.5-15.5. Here, we report that Skp2(-/-);Rb1(-/-) embryos died on F11.5, establishing an organismal level synthetic lethal relationship between Rbi and Skp2. On E10.5, Rb1(-/-) placentas showed similarly active proliferation and similarly inactive apoptosis as WT placenta, whereas Rb1(-/-) embryos showed ectopic proliferation without increased apoptosis in the brain. Combining Skp2-1did not reduce proliferation or increase apoptosis in the placentas but induced extensive apoptosis in the brain. We conditionally deleted Rb1 in neuronal lineage with Nes-Cre and reproduced the brain apoptosis in E13.5 Nes-Cre; Rb1(-/-);Skp2(-/-) embryos, demonstrating their synthetic lethal relationship at a cell autonomous level. Nes-Cre-mediated.Rbl deletion increased expression of proliferative E2F target genes in the brains of Skp2(+/+) embryos; the increases rose higher with activation of expression of apoptotic E2F target genes in Skp2(-/-) embryos. The brain apoptosis was independent of p53 but coincident with proliferation. The highly activated expression of proliferative and apoptotic E2F target genes subsided with gradually reduced roles of Skp2 in preventing p27 protein accumulation in the brain in late gestation, allowing the embryos to reach full term with normally sized brains. These findings establish that Rbi and Skp2 deletions are synthetic lethal and suggest how this lethal relationship might be circumvented, which could help design better therapies for pRb-deficient cancer.
引用
收藏
页码:10201 / 10209
页数:9
相关论文
共 50 条
  • [1] BEYOND ONCOGENESIS: THE ROLE OF S-PHASE KINASE-ASSOCIATED PROTEIN-2 (SKP2) IN VASCULAR RESTENOSIS
    Wu, Yih-Jer
    Yehl, Hung-I
    Hou, Charles Jia-Yin
    Tsai, Cheng-Ho
    Newby, Andrew C.
    Bond, Mark
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2008, 2 (04) : 158 - 166
  • [2] Discovery of Novel 1,3-Diphenylpyrazine Derivatives as Potent S-Phase Kinase-Associated Protein 2 (Skp2) Inhibitors for the Treatment of Cancer
    Zhang, Kun
    Hu, Kaizhao
    Li, Qian
    Li, Min
    Gao, Ke
    Yang, Kecheng
    Zhao, Bing
    Shi, Xiao-Jing
    Zhang, Lirong
    Liu, Hong-Min
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (11) : 7221 - 7242
  • [3] Silencing of the S-Phase Kinase-Associated Protein 2 Gene (SKP2) Inhibits Proliferation and Migration of Hepatocellular Carcinoma Cells
    Zhao, Y. Y.
    Gao, Z. X.
    Wei, S. D.
    Song, W.
    MOLECULAR BIOLOGY, 2024, 58 (06) : 1197 - 1207
  • [4] Merkel cell carcinomas: Expression of S-phase kinase-associated protein 2 (Skp2), p27, and proliferation markers
    Erickson, LA
    Papotti, M
    Volante, M
    Jin, L
    Lewis, JE
    Lloyd, RV
    ENDOCRINE PATHOLOGY, 2003, 14 (03) : 221 - 229
  • [5] Flavokawains degrade S-phase kinase-associated protein 2 (Skp2) via deneddylation of cullin-1 and inhibit prostate cancer in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model
    Li, Xuesen
    Liu, Zhongbo
    Liu, Shuman
    Xu, Xia
    Sun, Zheng
    Blair, Christopher A.
    Simoneau, Anne R.
    Zi, Xiaolin
    CANCER RESEARCH, 2011, 71
  • [6] Merkel cell carcinomas: expression of S-phase kinase-associated protein 2 (Skp2), p27, and proliferation markers
    Lori A. Erickson
    Mauro Papotti
    Marco Volante
    Long Jin
    Jean E. Lewis
    Ricardo V. Lloyd
    Endocrine Pathology, 2003, 14 (3) : 221 - 229
  • [7] Discovery of Novel [1,2,4]Triazolo[1,5-a]pyrimidine Derivatives as Novel Potent S-Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
    Hu, Kaizhao
    Luo, Yongqiang
    Miao, Peipei
    Zhao, Lidan
    Zhao, Bing
    Shi, Xiao-Jing
    Liu, Hong-Min
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (18) : 16435 - 16454
  • [8] S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo
    Wu, Yih-Jer
    Sala-Newby, Graciela B.
    Shu, Kuo-Tung
    Yeh, Hung-I
    Nakayama, Keiichi I.
    Nakayama, Keiko
    Newby, Andrew C.
    Bond, Mark
    JOURNAL OF VASCULAR SURGERY, 2009, 50 (05) : 1135 - 1142
  • [9] cAMP inhibits vascular smooth muscle cell proliferation via RAC1-dependent regulation of S-phase kinase-associated protein-2 (Skp2)
    Wu, Yih-Jer
    Newby, Andrew C.
    Sala-Newby, Graciela B.
    Hsu, Kuo-Tung
    Tseng, Sywoei
    Yeh, Hung-I.
    Bond, Mark
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 49 - 49
  • [10] The effects of S-phase kinase-associated protein 2 (SKP2) on cell cycle status, viability, and chemoresistance in A549 lung adenocarcinoma cells
    Ishii, T
    Matsuse, T
    Masuda, M
    Teramoto, S
    EXPERIMENTAL LUNG RESEARCH, 2004, 30 (08) : 687 - 703